Lynne Hughes, VP and head of medical CNS strategy at IQVIA, talked about EPAD accomplishments and challenges in an interview article. She provided insights on how EPAD and IQVIA are contributing to advance Alzheimer’s disease research. EPAD is celebrating five years since its inception. What has it accomplished? We have 23 European sites enrolling subjects…
The EPAD project, originally scheduled to end in December 2019, has been extended. We are pleased to share that IMI has officially approved our request for a 6-month no-cost extension to the project, setting the end date in June 2020. This extension will allow the delivery of the start of the first EPAD Proof of…
The Neuronet (Efficiently Networking European Neurodegeneration Research) communication team is proud to announce the launch of the official project website: http://imi-neuronet.org/ Neuronet is a three-year coordination and support action that kicked off in March 2019. The aim of Neuronet is to set up an efficient platform to boost collaboration across research projects focusing on neurodegenerative…
Members of the EPAD team attended the Alzheimer’s Association International Conference (AAIC) held on 14-18 July. They travelled to Los Angeles (US) from across Europe for the biggest event in dementia research. The event featured a number of key symposia, focused topic sessions and poster presentations and highlighted significant progress, results and theories that will help…
What is your current role in EPAD? Within the Geneva University, I act as a project manager for both EPAD and the AMYPAD Prognostic Natural History Study (PNHS). This includes all the tasks incumbent to this function, ranging from the submissions to the Ethics committee, the follow up of the speed of recruitment, the identification of some deviations…
What is your current role in EPAD? I am a Project Manager at IXICO plc, and I manage the delivery of Magnetic Resonance Imaging (MRI) analysis results on EPAD Longitudinal Cohort Study. IXICO data analysis algorithms quantitatively analyse brain scans, to maximise the information extracted and increase chances of detecting therapy-induced changes in clinical trials.…
This month, we get to know the North Bristol centre behind EPAD. The team of Elizabeth Coulthard (principal investigator of the EPAD project in North Bristol) began recruiting in June 2018 and has currently recruited 40 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with her team and asked them a few…
From 15-17 May 2019, the EPAD project hosted its annual General Assembly meeting in Geneva (Switzerland). We were delighted that the event brought together EPAD delegates to discuss progress, latest developments and future plans. In attendance were scientists, researchers, representatives from pharmaceutical companies, patient organisations, SMEs, EPAD study site members, other experts and research participants…
This month, we get to know the Karolinska Institutet centre behind EPAD. The team of Miia Kivipelto (principal investigator of the EPAD project in Karolinska Institutet) began recruiting in August 2017 and has currently recruited 32 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with her team and asked them a few…
On 4 April, the CHU de Toulouse (CHUT) hosted the first meeting of the Research Participant Panel of the European Prevention of Alzheimer’s Dementia Consortium (EPAD) in France. We caught up with a French Research participant to know what it is like to take part in a research study and find out about his experiences.…
